General In Vitro Diagnostics: research reports

In Vitro Diagnostics (IVD) are tests done to provide medical information by using medical devices and examinations in vitro (derived from the human body and evaluated from assays in a test tube). These tests can be used to detect diseases, conditions or infections.

The IVD services industry has grown tremendously in the past few years, estimated to have reached $44 Billion in 2010. As this industry continues to grow due to technological advances, significant developments in diagnostic services, and active private sector participation, it is estimated to reach about $52 Billion by the end of 2013.

Other factors contributing to this immense growth in the IVD services industry are increasing disease prevalence and high disposable income.

Innovation in technology is expected to play a vital role in the future of this industry. The point-of-care segment makes up the largest part of the global IVD market, followed by immunochemistry and molecular diagnostics. These segments are likely to continue growing immensely, as healthcare spending is increasing across the globe. Tests for diseases, such as diabetes, cardiovascular, and cancer, are providing strong support to the industry developments. In addition, the influenza diagnostic services are expected to contribute to the global IVD industry growth during the 2011-2013 forecast period.